Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.83
BATS BZX Real-Time Price
As of 2:52pm ET
 -0.09 / -0.76%
Today’s Change
5.53
Today|||52-Week Range
13.84
+4.69%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 16.00 and a low estimate of 13.00. The median estimate represents a +31.02% increase from the last price of 11.83.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$17.6M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.21%
 
 
 
 
 
 
Growthannually -37.50%
 
 
 
 
 
 

Sales

Growthquarterly 18.39%
 
 
 
 
 
 
Growthannually -22.77%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account